Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway

Partha Chakrabarti1, Ju Youn Kim, Maneet Singh

  • 1Boston University School of Medicine, Boston, Massachusetts, USA. pc1@csiriicb.in

Insights

Insulin inhibits fat breakdown by reducing adipose triglyceride lipase (ATGL) transcription. A conserved mTORC1-Egr1 pathway mediates this effect, revealing a key mechanism for insulin

Area of Science:

  • Molecular biology
  • Cell biology
  • Metabolic regulation

Background:

  • Insulin's role in inhibiting lipolysis (fat breakdown) in adipocytes is crucial for triglyceride storage.
  • Previous studies identified the mTORC1 pathway's involvement in reducing adipose triglyceride lipase (ATGL) transcription, but the precise mechanism was unclear.

Purpose of the Study:

  • To identify the transcription factor mediating the effect of Tor1 on ATGL ortholog expression in yeast.
  • To elucidate the molecular mechanism by which insulin inhibits lipolysis in mammalian cells.

Main Methods:

  • Genetic screen in Saccharomyces cerevisiae to identify transcription factors.
  • In vitro assays to assess ATGL promoter activity.
  • Experiments using cultured adipocytes and animal models (high-fat diet).

Main Results:

  • A yeast transcription factor, Msn4p, was identified as mediating Tor1's effect on ATGL ortholog expression.
  • Msn4p homologues in mammals include early growth response transcription factors, such as Egr1.
  • Egr1 is induced by insulin and nutrients, directly inhibits ATGL promoter activity, and reduces ATGL expression in adipocytes.
  • High-fat diet increases mTORC1 activity and Egr1 expression while decreasing ATGL levels in epididymal fat.

Conclusions:

  • The mTORC1-Egr1-ATGL regulatory pathway is evolutionarily conserved.
  • This pathway is a significant component of insulin's antilipolytic effect in mammals.
  • Understanding this pathway offers insights into metabolic regulation and triglyceride storage.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...